| Dr David R Chavez, MD | |
|
One Medical Center Dr, Lebanon, NH 03756-0001 | |
| (603) 653-9882 | |
| (603) 653-0908 |
| Full Name | Dr David R Chavez |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 36 Years |
| Location | One Medical Center Dr, Lebanon, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124110275 | NPI | - | NPPES |
| 0053278 | Medicaid | MT | |
| 118564100 | Medicaid | WY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
| Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
News Archive
A University of Kentucky researcher is investigating respiratory weakness as a factor in the morbidity of intensive-care patients and will soon be testing new treatments that could improve long-term patient outcomes while reducing costs of care.
Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
A pregnancy constantly overshadowed by the unknown. That is how women in Sweden who have been pregnant during the pandemic describe it.
› Verified 1 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
A University of Kentucky researcher is investigating respiratory weakness as a factor in the morbidity of intensive-care patients and will soon be testing new treatments that could improve long-term patient outcomes while reducing costs of care.
Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
A pregnancy constantly overshadowed by the unknown. That is how women in Sweden who have been pregnant during the pandemic describe it.
› Verified 1 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
A University of Kentucky researcher is investigating respiratory weakness as a factor in the morbidity of intensive-care patients and will soon be testing new treatments that could improve long-term patient outcomes while reducing costs of care.
Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
A pregnancy constantly overshadowed by the unknown. That is how women in Sweden who have been pregnant during the pandemic describe it.
› Verified 1 days ago
| Entity Name | Alliance Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891859419 PECOS PAC ID: 8022019215 Enrollment ID: O20070131000394 |
News Archive
A University of Kentucky researcher is investigating respiratory weakness as a factor in the morbidity of intensive-care patients and will soon be testing new treatments that could improve long-term patient outcomes while reducing costs of care.
Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
A pregnancy constantly overshadowed by the unknown. That is how women in Sweden who have been pregnant during the pandemic describe it.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David R Chavez, MD One Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 653-9882 | Dr David R Chavez, MD One Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 653-9882 |
News Archive
A University of Kentucky researcher is investigating respiratory weakness as a factor in the morbidity of intensive-care patients and will soon be testing new treatments that could improve long-term patient outcomes while reducing costs of care.
Cyberonics, Inc., a global leader in medical devices for the treatment and management of epilepsy, today announced that the U.S. Food and Drug Administration approved a significant expansion of options for Magnetic Resonance Imaging use by patients who have the VNS Therapy System.
Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.
A pregnancy constantly overshadowed by the unknown. That is how women in Sweden who have been pregnant during the pandemic describe it.
› Verified 1 days ago
Dr. John Derek Seigne, M.B. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc, Lebanon, NH 03756 Phone: 603-650-5091 | |
Roland N Chen, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Duncan Rogers Morhardt, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-653-9883 | |
Rachel Anna Moses, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Urology, Lebanon, NH 03756 Phone: 603-650-5091 | |
Dr. William Bihrle Iii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-6052 | |
Dr. Elizabeth Ann Gormley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Section Of Urology, Lebanon, NH 03756 Phone: 603-650-6053 |